Non Us — Collaboration revenues
Geographic · Collaboration revenuesAbbVie Non Us — Collaboration revenues decreased by 5.7% to $199.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.2%, from $210.00M to $199.00M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful international collaboration and effective monetization of shared intellectual property, while a decrease may indicate maturing partnerships or reduced market performance of jointly developed products.
Detailed definition
This metric represents the company's proportional share of profits derived from international collaborative arrangements...
Peer comparison
Comparable to 'equity method income' or 'collaboration revenue' reported by other large-cap pharmaceutical firms engaged in co-development or co-promotion agreements.
abbv_segment_international_collaboration_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $282.00M | $265.00M | $299.00M | $283.00M | $286.00M | $240.00M | $241.00M | $230.00M | $228.00M | $238.00M | $210.00M | $209.00M | $211.00M | $199.00M |
| QoQ Change | — | -6.0% | +12.8% | -5.4% | +1.1% | -16.1% | +0.4% | -4.6% | -0.9% | +4.4% | -11.8% | -0.5% | +1.0% | -5.7% |
| YoY Change | — | — | — | +0.4% | +7.9% | -19.7% | -14.8% | -19.6% | -5.0% | -1.2% | -8.7% | -8.3% | -11.3% | -5.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's non us — collaboration revenues?
- AbbVie (ABBV) reported non us — collaboration revenues of $199.00M in Q3 2025.
- How has AbbVie's non us — collaboration revenues changed year-over-year?
- AbbVie's non us — collaboration revenues decreased by 5.2% year-over-year, from $210.00M to $199.00M.
- What does non us — collaboration revenues mean?
- The company's portion of profits earned from international partnerships and joint business ventures.